Plain-English translation of NCT06343298 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a medication called , given as a daily injection under the skin, to see if it can help lower blood pressure in people whose condition is hard to control. You would receive either the new medication or a placebo (inactive injection) for 42 days. The study will measure whether the medication safely reduces your blood pressure compared to placebo.
Many people with high blood pressure don't reach their goal blood pressure even when taking three or more different medications. This medication is being tested to see if it offers a new treatment option for people in this situation.
You likely qualify if…
You likely don't qualify if…
You would visit the study site regularly over 42 days to receive daily injections of either the new medication or placebo under your skin. The study team will monitor your blood pressure using a 24-hour ambulatory monitor, check your blood work, and track how you're tolerating the treatment. You'll receive either the medication or placebo through dose adjustments over the study period to find the right dose for you.
AI-generated summary from trial data · Jul 4, 2026 · Not medical advice
United States